MX2021006189A - Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal. - Google Patents
Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal.Info
- Publication number
- MX2021006189A MX2021006189A MX2021006189A MX2021006189A MX2021006189A MX 2021006189 A MX2021006189 A MX 2021006189A MX 2021006189 A MX2021006189 A MX 2021006189A MX 2021006189 A MX2021006189 A MX 2021006189A MX 2021006189 A MX2021006189 A MX 2021006189A
- Authority
- MX
- Mexico
- Prior art keywords
- fucosyllactose
- improve
- gastrointestinal barrier
- nutritional composition
- barrier
- Prior art date
Links
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 title abstract 3
- 230000004888 barrier function Effects 0.000 title abstract 3
- 230000002496 gastric effect Effects 0.000 title abstract 3
- 229940062827 2'-fucosyllactose Drugs 0.000 title abstract 2
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 title abstract 2
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
La presente invención se relaciona con composiciones nutricionales que comprenden 2'-fucosillactosa (2'FL) para usar en el mejoramiento de la barrera gastrointestinal. En particular, la presente invención se relaciona con mejorar la barrera gastrointestinal en un infante, un niño pequeño o niños mayores de 3 años a 8 años de edad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18215208 | 2018-12-21 | ||
PCT/EP2019/084572 WO2020126726A1 (en) | 2018-12-21 | 2019-12-11 | A nutritional composition comprising 2'-fucosyllactose (2' fl) to improve the gastrointestinal barrier |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021006189A true MX2021006189A (es) | 2021-06-23 |
Family
ID=65030858
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021006189A MX2021006189A (es) | 2018-12-21 | 2019-12-11 | Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal. |
MX2021006178A MX2021006178A (es) | 2018-12-21 | 2019-12-11 | Una composicion nutricional que comprende una combinacion de oligosacaridos de la leche humana para mejorar la barrera gastrointestinal. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021006178A MX2021006178A (es) | 2018-12-21 | 2019-12-11 | Una composicion nutricional que comprende una combinacion de oligosacaridos de la leche humana para mejorar la barrera gastrointestinal. |
Country Status (8)
Country | Link |
---|---|
US (2) | US20220062311A1 (es) |
EP (2) | EP3897208A1 (es) |
CN (2) | CN113226062A (es) |
AU (2) | AU2019411483A1 (es) |
DE (1) | DE202019005475U1 (es) |
MX (2) | MX2021006189A (es) |
PH (2) | PH12021551077A1 (es) |
WO (2) | WO2020126726A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180078572A1 (en) * | 2015-03-05 | 2018-03-22 | Nestec S.A. | Compositions for use in improving stool consistency or frequency in infants or young children |
US12005083B1 (en) | 2019-06-24 | 2024-06-11 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
US11849747B1 (en) | 2019-06-24 | 2023-12-26 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
CN112890200B (zh) * | 2021-03-08 | 2021-11-12 | 合生元(广州)健康产品有限公司 | 用于促进低体重婴幼儿生长追赶的一种营养组合物 |
CN113796546A (zh) * | 2021-09-13 | 2021-12-17 | 合生元(广州)健康产品有限公司 | 改善肠道屏障功能母乳低聚糖组合物及其应用 |
CN114271340A (zh) * | 2021-11-30 | 2022-04-05 | 内蒙古伊利实业集团股份有限公司 | 一种含有乳糖-n-四糖的配方奶粉及其制备方法与应用 |
CN114452295A (zh) * | 2021-11-30 | 2022-05-10 | 内蒙古伊利实业集团股份有限公司 | 乳糖-n-四糖用于预防肠漏的应用 |
CN114128767B (zh) * | 2021-11-30 | 2023-12-22 | 内蒙古伊利实业集团股份有限公司 | 含有母乳低聚糖的乳蛋白部分水解低致敏性婴儿配方食品 |
CN114451453B (zh) * | 2021-11-30 | 2024-01-30 | 内蒙古伊利实业集团股份有限公司 | 用于预防肠漏的母乳低聚糖组合物及其应用 |
WO2023203501A1 (en) * | 2022-04-22 | 2023-10-26 | Health And Happiness (H&H) Hong Kong Ltd | 2'-fucosyllactose and 6'-sialyllactose for modulating the immune system |
CN114886119B (zh) * | 2022-06-10 | 2023-11-28 | 江南大学 | 3’-唾液酸乳糖在制备缓解食物过敏的功能性食品中的应用 |
CN115918916A (zh) * | 2022-11-29 | 2023-04-07 | 黑龙江飞鹤乳业有限公司 | 含母乳低聚糖和乳铁蛋白的营养组合物、食品及用途 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
PL1638416T3 (pl) * | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
MX350782B (es) * | 2011-07-22 | 2017-09-18 | Abbott Lab | Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
MX368124B (es) * | 2011-08-29 | 2019-09-19 | Abbott Lab | Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
ES2856053T3 (es) * | 2014-10-29 | 2021-09-27 | Glycom As | Composición sintética y procedimiento para promover la cicatrización de la mucosa |
US11040050B2 (en) * | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
CN107106584A (zh) | 2014-12-08 | 2017-08-29 | 格礼卡姆股份公司 | 用于治疗代谢障碍的合成组合物 |
DE202016008919U1 (de) * | 2015-03-05 | 2020-09-07 | Société des Produits Nestlé S.A. | Zusammensetzungen zur Verwendung bei der Prävention oder Behandlung von gastrointestinalen Infektionen/Entzündungen bei Säuglingen oder Kleinkindern |
US20180078572A1 (en) * | 2015-03-05 | 2018-03-22 | Nestec S.A. | Compositions for use in improving stool consistency or frequency in infants or young children |
WO2017046711A1 (en) | 2015-09-14 | 2017-03-23 | Glycom A/S | Synthetic composition for microbiota modulation |
WO2017071716A1 (en) | 2015-10-28 | 2017-05-04 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
EP3419630A4 (en) | 2016-02-24 | 2019-11-06 | Glycom A/S | SYNTHETIC COMPOSITION OF MICROBIOTIC MODULATION |
EP4382108A2 (en) * | 2017-05-09 | 2024-06-12 | Société des Produits Nestlé S.A. | Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes |
AU2018387279A1 (en) * | 2017-12-21 | 2020-05-07 | Societe Des Produits Nestle S.A. | Compositions comprising at least on N-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children |
CN111432661A (zh) | 2017-12-22 | 2020-07-17 | 雀巢产品有限公司 | 用途是用于减少婴儿和幼儿的伤害感觉的组合物 |
-
2019
- 2019-12-11 US US17/416,573 patent/US20220062311A1/en active Pending
- 2019-12-11 CN CN201980083069.6A patent/CN113226062A/zh active Pending
- 2019-12-11 EP EP19813904.0A patent/EP3897208A1/en active Pending
- 2019-12-11 MX MX2021006189A patent/MX2021006189A/es unknown
- 2019-12-11 AU AU2019411483A patent/AU2019411483A1/en active Pending
- 2019-12-11 AU AU2019400658A patent/AU2019400658A1/en active Pending
- 2019-12-11 US US17/416,571 patent/US20220079963A1/en active Pending
- 2019-12-11 MX MX2021006178A patent/MX2021006178A/es unknown
- 2019-12-11 EP EP19813901.6A patent/EP3897207A1/en active Pending
- 2019-12-11 CN CN201980082969.9A patent/CN113194746A/zh active Pending
- 2019-12-11 WO PCT/EP2019/084572 patent/WO2020126726A1/en unknown
- 2019-12-11 WO PCT/EP2019/084604 patent/WO2020126734A1/en unknown
- 2019-12-11 DE DE202019005475.8U patent/DE202019005475U1/de active Active
-
2021
- 2021-05-05 PH PH12021551077A patent/PH12021551077A1/en unknown
- 2021-05-05 PH PH12021551074A patent/PH12021551074A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3897207A1 (en) | 2021-10-27 |
MX2021006178A (es) | 2021-06-18 |
PH12021551077A1 (en) | 2021-12-06 |
DE202019005475U1 (de) | 2020-09-23 |
US20220079963A1 (en) | 2022-03-17 |
AU2019400658A1 (en) | 2021-06-03 |
AU2019411483A1 (en) | 2021-06-03 |
CN113194746A (zh) | 2021-07-30 |
US20220062311A1 (en) | 2022-03-03 |
WO2020126726A1 (en) | 2020-06-25 |
EP3897208A1 (en) | 2021-10-27 |
CN113226062A (zh) | 2021-08-06 |
WO2020126734A1 (en) | 2020-06-25 |
PH12021551074A1 (en) | 2021-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021551074A1 (en) | A nutritional composition comprising 2`-fucosyllactose (2` fl) to improve the gastrointestinal barrier | |
MX2021005975A (es) | Una composicion nutricional que comprende 6'sl y lnt en combinacion para mejorar la funcion de la barrera gastrointestinal. | |
PH12017550040A1 (en) | Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children | |
PH12017550041A1 (en) | Compositions for use in improving stool consistency or frequency in infants or young children | |
PH12017550044A1 (en) | Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children | |
EP3616716A3 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
MX2018008955A (es) | Composiciones que comprenden oligosacaridos de la leche humana para usar en infantes o niños pequeños para prevenir o tratar un trastorno de la salud al aumentar la secrecion de glp-1. | |
MX2016007178A (es) | Glucosidos de triterpeno novedosos como edulcorantes o potenciadores de edulcorantes. | |
PH12015502543A1 (en) | Anti-regurgitation composition maintaining gut motility | |
PH12016500761A1 (en) | Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection | |
PH12018501324A1 (en) | COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN | |
PH12018501262A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies | |
PH12021551075A1 (en) | A NUTRITIONAL COMPOSITION COMPRISING METABOLITES OF HMOs TO IMPROVE THE GASTROINTESTINAL BARRIER | |
MX369524B (es) | Composicion edulcorante novedosa. | |
MX347403B (es) | Composiciones anti-regurgitacion y/o anti-reflujo gastroesofagico, preparacion y usos. | |
WO2016198170A8 (en) | Vaccines against streptococcus pneumoniae serotype 5 | |
PH12018500953A1 (en) | Nutritional compositions and infant formulas to promote myelination in the brain | |
PH12019500092A1 (en) | Nutritional compositions for infants and/or young children comprising oligosaccharides | |
PH12021550816A1 (en) | Nutritional composition comprising 2'fucosyllactose and dietary butyrate | |
MX2022004133A (es) | Composicion que contiene b caseina a2 para favorecer un mejor temperamento en mamiferos jovenes. | |
WO2020245313A8 (en) | Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose | |
MX2016000195A (es) | Oligosacaridos sinteticos para vacuna de p. aeruginosa. | |
MX2018006296A (es) | Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro. | |
MX2018005134A (es) | Formulacion de factor viii (fviii). | |
PH12017500466A1 (en) | Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children |